U.S. REITS Stock News

Greenbrier Companies (GBX) has quietly outperformed the broader market over the past month, even though the stock is still down sharply year to date. This invites a closer look at what investors might be missing. See our latest analysis for Greenbrier Companies. Over the past year, Greenbrier’s share price return has been weak. However, a recent 1 month share price return of 8.6 percent from around 46.6 dollars suggests momentum may be starting to rebuild as investors reassess rail related...

Intuitive Machines (LUNR) has had a choppy run lately, with the stock down over the past week but still up in the past month and past 3 months, leaving investors reassessing its risk reward profile. See our latest analysis for Intuitive Machines. The 13.1% 1 month share price return and 16.2% 3 month share price return suggest momentum is tentatively rebuilding. However, the 44.2% year to date share price decline and weaker 1 year total shareholder return show investors are still pricing in...

In the past quarter, Collegium Pharmaceutical reported a strong Q3, with revenue rising 31.4% year on year and topping analyst expectations by 10.7%, driven by its differentiated pain management medicines. The company also exceeded its full-year revenue guidance, signaling operational strength that reinforces its focus on specialty products for chronic pain. With Q3 revenue surpassing expectations by 10.7%, we’ll now examine how this performance influences Collegium’s existing investment...

If you have ever wondered whether Enterprise Products Partners is still a smart buy at today’s price, you are not alone. This breakdown is designed to give you a clear, valuation focused answer. Despite a modest pullback of around 1.7% over the last week and 1.5% over the last month, Enterprise is still up about 8.7% over the past year and 128.0% over five years. This indicates that the long term story has been much stronger than the recent noise. Recent coverage has highlighted Enterprise’s...

Corteva (CTVA) has quietly given back some gains over the past month, even as its year to date return remains solidly in positive territory, and that gap is catching investors attention. See our latest analysis for Corteva. That recent pullback sits against a backdrop of a much stronger year to date share price return of 16.2 percent and a 5 year total shareholder return of 77.5 percent, suggesting long term momentum remains intact even as near term enthusiasm cools. If Corteva has you...

If you are wondering whether Taiwan Semiconductor Manufacturing is still a smart buy after its huge run, or if you would be overpaying at today's price, you are not alone. TSM's share price has pulled back about 5.5% over the last week, but it is still up around 0.7% over 30 days and 42.3% year to date, with a 44.5% gain over 1 year and 293.5% over 3 years. That surge in returns has coincided with ongoing optimism around chip demand for AI data centers and high performance computing,...

Wondering if Exxon Mobil is still a buy after its huge run over the last few years, or if the easy money has already been made? You are not alone. Despite a 240.2% gain over 5 years and a solid 10.1% return over the last year, the stock has cooled recently, slipping 3.0% over the past week and 3.9% over the last month, while still up 6.9% year to date. Recent moves have been shaped by shifting expectations for long term oil and gas demand and renewed focus on energy security, as markets...

Wondering if Huntington Ingalls Industries is still a smart buy after its big run, or if the market has already priced in the upside? This breakdown will walk through what the current share price really implies. The stock has climbed to around $326.80, with gains of 3.8% over the last week, 4.1% over the last month, and 74.2% year to date, building on a 72.9% 1-year return and 123.6% over 5 years that has clearly shifted how investors see its prospects and risks. That re-rating has been...

Crocs (CROX) has quietly staged a comeback, with shares up roughly 25% over the past month and about 14% in the past 3 months, despite flat revenue and volatile long term returns. See our latest analysis for Crocs. Zooming out, that strong 1 month share price return contrasts with a negative year to date share price return and a weak 1 year total shareholder return, hinting that sentiment may be turning after a choppy stretch. If Crocs has you rethinking where growth might show up next in...

Occidental Petroleum (OXY) has been grinding lower, with the stock down about 9% over the past month and roughly 18% over the past 3 months, inviting a closer look at valuation and expectations. See our latest analysis for Occidental Petroleum. That slide comes after a choppy year, where the share price has delivered a weak year to date return and a negative one year total shareholder return. This suggests momentum has faded as the market reassesses energy price risks and Occidental...

Invitation Homes (INVH) just gave income focused investors something new to consider with a 3.4% increase in its quarterly dividend, along with stronger than expected revenue and higher 2025 cash flow guidance. See our latest analysis for Invitation Homes. Those stronger fundamentals have not yet translated into the share price, with a year to date share price return of negative 14.6 percent and a one year total shareholder return of negative 14.1 percent. This suggests momentum has been...

Philip Morris International (PM) has quietly turned into one of 2024’s steadier compounders, with the stock up around 30% over the past year as investors warm to its smoke free transition story. See our latest analysis for Philip Morris International. That steady grind higher has come as the market leans into Philip Morris International’s smoke free and wellness push. The latest $157.95 share price sits on the back of a roughly 30 percent year to date share price return and a 5 year total...

Cytokinetics (CYTK) just cleared two big regulatory hurdles for its heart drug MYQORZO, with full approval in China and a positive EU opinion, and that one-two punch is reshaping how investors view its pipeline. See our latest analysis for Cytokinetics. The stock has been choppy in the short term, with a 1 month share price return of minus 6.7 percent. However, a 90 day share price return above 30 percent and a 1 year total shareholder return just under 30 percent suggest momentum is still...

If you are wondering whether Centene is a beaten down bargain or a value trap at current prices, this article will walk through what the numbers are really saying about the stock. Despite being down 35.6% year to date and 32.6% over the past year, the share price has shown some recent stability, with a 2.3% gain over the last week and 7.1% over the last month. Much of the recent price action has been shaped by shifting expectations around US healthcare policy and Medicaid redeterminations,...

If you are wondering whether KLA is still a smart buy after its huge run, or if the easy money has already been made, you are not alone. That is exactly what we will unpack here. Despite a slight dip of 0.2% over the last week, KLA is up 7.9% over the past month, 92.2% year to date, and 401.2% over five years. This naturally raises questions about how much upside may still be available. Much of this momentum has been driven by investors crowding into semiconductor and AI related names, with...

Wondering if Sea is still a smart buy after its roller coaster ride over the years, or if the easy money has already been made? The stock is up 18.5% year to date and 7.3% over the last year, but that comes after a sharp 38.1% drop over five years and a recent pullback of 11.8% in the last month. Investors have been reacting to shifts in Sea's core businesses, from its expanding digital financial services arm in Southeast Asia to ongoing efforts to stabilize growth in its e commerce and...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The board of The Toro Company ( NYSE:TTC ) has announced that it will be paying its dividend of $0.39 on the 12th of...

Some CME Group Inc. ( NASDAQ:CME ) shareholders may be a little concerned to see that the Chairman & CEO, Terrence...

Some The Carlyle Group Inc. ( NASDAQ:CG ) shareholders may be a little concerned to see that the Co-Founder...

Synopsys (SNPS) just got a confidence boost after Bank of America shifted to a more positive stance, citing strong Q4 revenue growth, successful Ansys integration, and healthier exposure to China and Intel. See our latest analysis for Synopsys. That upgrade lands after a volatile stretch where the share price slid earlier in the year but has recently regained momentum, with a 1 month share price return of 18.86 percent and a 3 year total shareholder return of 42.82 percent, still underscoring...

Rezolve AI stock reaction to recent performance Rezolve AI (RZLV) has experienced a choppy ride, with the share price up slightly over the past month but still down sharply over the past 3 months and year to date. See our latest analysis for Rezolve AI. The recent 1 day share price return of 28.02 percent has given RZLV a jolt of positive momentum, but that sits against a much weaker 3 year total shareholder return of negative 70.48 percent, so sentiment is still in repair mode at a share...

Northwest Bancshares (NWBI) has quietly outperformed many regional peers over the past month, gaining about 8% while still sitting on a modest loss year to date. This makes the recent move worth unpacking. See our latest analysis for Northwest Bancshares. That recent 8% one month share price return has started to reverse some of Northwest Bancshares year to date weakness, and with the 5 year total shareholder return above 40%, the current 12.71 dollar share price suggests momentum is quietly...

MP Materials (MP) has quietly staged a sharp rebound this year, even as the stock has slid over the past month and past 3 months, leaving investors debating whether this pullback offers value. See our latest analysis for MP Materials. That pullback sits against a powerful backdrop, with the share price up sharply on a year to date basis and the one year total shareholder return near 191 percent, suggesting long term momentum is still intact even as short term sentiment cools. If MP’s rare...